# Nutraceutical Combination in Patients With Low-grade Systemic Inflammation

Study · id `cardio:ct-nct02422927` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02422927](<https://clinicaltrials.gov/study/NCT02422927>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02422927

Browse, organ or system: Blood vessels; Metabolism  
Browse, condition area: Risk and prevention; Coronary and vascular disease; Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT02422927. Randomized; single masking; primary purpose treatment. Start 2014-07 (registry gives no type); primary completion 2015-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT02422927, source copy `cardio:ctgov-nct02422927-2015-04-22`, retrieved 2026-10-31)
- Start date: 2014-07 (registry gives no type) (ClinicalTrials.gov record NCT02422927, source copy `cardio:ctgov-nct02422927-2015-04-22`, retrieved 2026-10-31)
- Primary completion: 2015-01 (actual) (ClinicalTrials.gov record NCT02422927, source copy `cardio:ctgov-nct02422927-2015-04-22`, retrieved 2026-10-31)
- Completion: 2015-02 (actual) (ClinicalTrials.gov record NCT02422927, source copy `cardio:ctgov-nct02422927-2015-04-22`, retrieved 2026-10-31)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02422927-2015-04-22`, retrieved 2026-10-31)

## The registry's words

- Brief title: Nutraceutical Combination in Patients With Low-grade Systemic Inflammation
- Condition: Atherosclerosis
- Condition: Inflammation
- Condition: Hypercholesterolemia
- Intervention (Dietary supplement): Nutraceutical Combination
- Intervention (Other): Standard of Care
- Intervention (Other): Placebo
- Lead sponsor: University Of Perugia
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry condition terms include this condition: High cholesterol (hypercholesterolemia) (`cardio:hypercholesterolemia`)

## Provenance

Content hash: fb7ea684f288143a810fe41c44e0a80cfb496a287a27738f50d2843c36053080
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
